(Q48630358)

English

Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis.

scientific article published in September 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9268236

Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis. (English)

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9268236

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Moses Rodriguez

3

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9268236

author name string

Hunter SF

1

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9268236

Miller DJ

2

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9268236

publication date

1 September 1997

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9268236

Journal of the Neurological Sciences

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9268236

150

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9268236

2

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9268236

103-113

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9268236

Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

The natural autoantibodies system: between hypotheses and facts

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Glycolipids and transmembrane signaling in oligodendroglia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Ligand binding to the cell surface receptor for reovirus type 3 stimulates galactocerebroside expression by developing oligodendrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Antibody to galactocerebroside alters organization of oligodendroglial membrane sheets in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Galactocerebroside and sulfatide independently mediate Ca2+ responses in oligodendrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Myelin/oligodendrocyte-specific protein: a novel surface membrane protein that associates with microtubules

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Pharmacokinetics of reshaped MAb 425 in three animal species

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Bipotential glial progenitors are targets of neuronal cell line-derived growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Growth factor responses of enriched bipotential glial progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

O-2A glial progenitors from mature brain respond to CNS neuronal cell line-derived growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Multiple sclerosis: a unique immunopathological syndrome of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Stimulation of myelin lipid synthesis in vitro by white matter antiserum in absence of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Spontaneous central nervous system remyelination in strain A mice after infection with the Daniel's (DA) strain of Theiler's virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Spontaneous CNS remyelination in beta 2 microglobulin-deficient mice following virus-induced demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Multi-organ reactivity of a monoclonal natural autoantibody that promotes remyelination in a mouse model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Multiple sclerosis. Pathology of recurrent lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Immunoglobulins promote remyelination in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Remyelination by oligodendrocytes stimulated by antiserum to spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Oligodendrocyte injury is an early event in lesions of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Immunoglobulins reactive with myelin basic protein promote CNS remyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

INTRAV and ORAL: BASIC interactive computer programs for estimating pharmacokinetic parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

Proteolipid protein gene expression in demyelination and remyelination of the central nervous system: a model for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900080-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-510X(97)00080-4

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9268236

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9268236

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48630358&oldid=2143519774"